Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2027

Global and China Parkinson's Disease (PD) Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Parkinson's Disease (PD) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Market by Application
1.3.1 Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Family
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Parkinson's Disease (PD) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Parkinson's Disease (PD) Drugs Revenue 2016-2027
2.1.2 Global Parkinson's Disease (PD) Drugs Sales 2016-2027
2.2 Global Parkinson's Disease (PD) Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Parkinson's Disease (PD) Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Parkinson's Disease (PD) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Parkinson's Disease (PD) Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027)
3 Global Parkinson's Disease (PD) Drugs Competitor Landscape by Players
3.1 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Sales
3.1.1 Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Parkinson's Disease (PD) Drugs Manufacturers by Revenue
3.2.1 Key Parkinson's Disease (PD) Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Parkinson's Disease (PD) Drugs Revenue in 2020
3.2.6 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Parkinson's Disease (PD) Drugs Price by Manufacturers
3.4 Global Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Type (2016-2021)
4.1.1 Global Parkinson's Disease (PD) Drugs Sales by Type (2016-2021)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Type (2016-2021)
4.1.3 Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Parkinson's Disease (PD) Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Parkinson's Disease (PD) Drugs Market Size by Application (2016-2021)
5.1.1 Global Parkinson's Disease (PD) Drugs Sales by Application (2016-2021)
5.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Application (2016-2021)
5.1.3 Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
5.2 Parkinson's Disease (PD) Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
6.1.1 China Parkinson's Disease (PD) Drugs Sales YoY Growth 2016-2027
6.1.2 China Parkinson's Disease (PD) Drugs Revenue YoY Growth 2016-2027
6.1.3 China Parkinson's Disease (PD) Drugs Market Share in Global Market 2016-2027
6.2 China Parkinson's Disease (PD) Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Parkinson's Disease (PD) Drugs Players by Sales (2016-2021)
6.2.2 China Top Parkinson's Disease (PD) Drugs Players by Revenue (2016-2021)
6.3 China Parkinson's Disease (PD) Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Parkinson's Disease (PD) Drugs Price by Type (2016-2021)
6.4 China Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Parkinson's Disease (PD) Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Parkinson's Disease (PD) Drugs Price Forecast by Type (2022-2027)
6.5 China Parkinson's Disease (PD) Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Parkinson's Disease (PD) Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Parkinson's Disease (PD) Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Parkinson's Disease (PD) Drugs Price by Application (2016-2021)
6.6 China Parkinson's Disease (PD) Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Parkinson's Disease (PD) Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
7.2 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
7.2.1 North America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
7.2.2 North America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
9.2 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
9.2.1 Europe Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
9.2.2 Europe Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
10.2.1 Latin America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
10.2.2 Latin America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Boehringer Ingelheim
12.1.1 Boehringer Ingelheim Corporation Information
12.1.2 Boehringer Ingelheim Description and Business Overview
12.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
12.1.5 Boehringer Ingelheim Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Description and Business Overview
12.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
12.3.5 Novartis Recent Development
12.4 Teva Pharmaceutical Industries
12.4.1 Teva Pharmaceutical Industries Corporation Information
12.4.2 Teva Pharmaceutical Industries Description and Business Overview
12.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
12.4.5 Teva Pharmaceutical Industries Recent Development
12.5 AbbVie
12.5.1 AbbVie Corporation Information
12.5.2 AbbVie Description and Business Overview
12.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
12.5.5 AbbVie Recent Development
12.6 Abital Pharma
12.6.1 Abital Pharma Corporation Information
12.6.2 Abital Pharma Description and Business Overview
12.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
12.6.5 Abital Pharma Recent Development
12.7 Addex Therapeutics
12.7.1 Addex Therapeutics Corporation Information
12.7.2 Addex Therapeutics Description and Business Overview
12.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
12.7.5 Addex Therapeutics Recent Development
12.8 Biogen
12.8.1 Biogen Corporation Information
12.8.2 Biogen Description and Business Overview
12.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
12.8.5 Biogen Recent Development
12.9 Eisai
12.9.1 Eisai Corporation Information
12.9.2 Eisai Description and Business Overview
12.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
12.9.5 Eisai Recent Development
12.10 Eli Lilly
12.10.1 Eli Lilly Corporation Information
12.10.2 Eli Lilly Description and Business Overview
12.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
12.10.5 Eli Lilly Recent Development
12.11 Boehringer Ingelheim
12.11.1 Boehringer Ingelheim Corporation Information
12.11.2 Boehringer Ingelheim Description and Business Overview
12.11.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
12.11.5 Boehringer Ingelheim Recent Development
12.12 H. Lundbeck
12.12.1 H. Lundbeck Corporation Information
12.12.2 H. Lundbeck Description and Business Overview
12.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 H. Lundbeck Products Offered
12.12.5 H. Lundbeck Recent Development
12.13 Impax Laboratories
12.13.1 Impax Laboratories Corporation Information
12.13.2 Impax Laboratories Description and Business Overview
12.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Impax Laboratories Products Offered
12.13.5 Impax Laboratories Recent Development
12.14 Kyowa Hakko Kirin
12.14.1 Kyowa Hakko Kirin Corporation Information
12.14.2 Kyowa Hakko Kirin Description and Business Overview
12.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Kyowa Hakko Kirin Products Offered
12.14.5 Kyowa Hakko Kirin Recent Development
12.15 Otsuka Pharmaceutical
12.15.1 Otsuka Pharmaceutical Corporation Information
12.15.2 Otsuka Pharmaceutical Description and Business Overview
12.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Otsuka Pharmaceutical Products Offered
12.15.5 Otsuka Pharmaceutical Recent Development
12.16 Pfizer
12.16.1 Pfizer Corporation Information
12.16.2 Pfizer Description and Business Overview
12.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Pfizer Products Offered
12.16.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Parkinson's Disease (PD) Drugs Industry Trends
13.2 Parkinson's Disease (PD) Drugs Market Drivers
13.3 Parkinson's Disease (PD) Drugs Market Challenges
13.4 Parkinson's Disease (PD) Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Parkinson's Disease (PD) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dopamine Agonist
Table 3. Major Manufacturers of Monoamine Oxidase Inhibitors
Table 4. Major Manufacturers of Acetylcholinesterase Inhibitors
Table 5. Major Manufacturers of Glutamate Inhibitors
Table 6. Global Parkinson's Disease (PD) Drugs Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 7. Global Parkinson's Disease (PD) Drugs Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Parkinson's Disease (PD) Drugs Sales by Regions (2016-2021) & (K Pcs)
Table 9. Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Parkinson's Disease (PD) Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Parkinson's Disease (PD) Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 12. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Parkinson's Disease (PD) Drugs Sales by Manufacturers (2016-2021) (K Pcs)
Table 16. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Parkinson's Disease (PD) Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Parkinson's Disease (PD) Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Parkinson's Disease (PD) Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2020)
Table 22. Key Manufacturers Parkinson's Disease (PD) Drugs Price (2016-2021) (USD/Pcs)
Table 23. Parkinson's Disease (PD) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 25. Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Parkinson's Disease (PD) Drugs Sales by Type (2016-2021) (K Pcs)
Table 28. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table 29. Global Parkinson's Disease (PD) Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2016-2021)
Table 31. Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 32. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 33. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Parkinson's Disease (PD) Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 37. Global Parkinson's Disease (PD) Drugs Sales by Application (2016-2021) (K Pcs)
Table 38. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Table 39. Global Parkinson's Disease (PD) Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Parkinson's Disease (PD) Drugs Revenue Share by Application (2016-2021)
Table 41. Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 42. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 43. Global Parkinson's Disease (PD) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Parkinson's Disease (PD) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Parkinson's Disease (PD) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 47. China Parkinson's Disease (PD) Drugs Sales (K Pcs) of Key Companies (2016-2021)
Table 48. China Parkinson's Disease (PD) Drugs Sales Share by Company (2016-2021)
Table 49. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. China Parkinson's Disease (PD) Drugs Revenue Share by Company (2016-2021)
Table 51. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2016-2021)
Table 52. China Parkinson's Disease (PD) Drugs Sales Share by Type (2016-2021)
Table 53. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 55. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Type (2022-2027)
Table 56. China Parkinson's Disease (PD) Drugs Sales Share by Type (2022-2027)
Table 57. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Parkinson's Disease (PD) Drugs Revenue Share by Type (2022-2027)
Table 59. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Type (2022-2027)
Table 60. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2016-2021)
Table 61. China Parkinson's Disease (PD) Drugs Sales Share by Application (2016-2021)
Table 62. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 64. China Parkinson's Disease (PD) Drugs Sales (K Pcs) by Application (2022-2027)
Table 65. China Parkinson's Disease (PD) Drugs Sales Share by Application (2022-2027)
Table 66. China Parkinson's Disease (PD) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Parkinson's Disease (PD) Drugs Revenue Share by Application (2022-2027)
Table 68. China Parkinson's Disease (PD) Drugs Price (USD/Pcs) by Application (2022-2027)
Table 69. North America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 70. North America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Parkinson's Disease (PD) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 74. Asia Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Parkinson's Disease (PD) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 78. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 82. Latin America Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 86. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Country (2016-2021)
Table 89. Boehringer Ingelheim Corporation Information
Table 90. Boehringer Ingelheim Description and Business Overview
Table 91. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 92. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 93. Boehringer Ingelheim Recent Development
Table 94. GlaxoSmithKline Corporation Information
Table 95. GlaxoSmithKline Description and Business Overview
Table 96. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Recent Development
Table 99. Novartis Corporation Information
Table 100. Novartis Description and Business Overview
Table 101. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 102. Novartis Product
Table 103. Novartis Recent Development
Table 104. Teva Pharmaceutical Industries Corporation Information
Table 105. Teva Pharmaceutical Industries Description and Business Overview
Table 106. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 107. Teva Pharmaceutical Industries Product
Table 108. Teva Pharmaceutical Industries Recent Development
Table 109. AbbVie Corporation Information
Table 110. AbbVie Description and Business Overview
Table 111. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 112. AbbVie Product
Table 113. AbbVie Recent Development
Table 114. Abital Pharma Corporation Information
Table 115. Abital Pharma Description and Business Overview
Table 116. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 117. Abital Pharma Product
Table 118. Abital Pharma Recent Development
Table 119. Addex Therapeutics Corporation Information
Table 120. Addex Therapeutics Description and Business Overview
Table 121. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 122. Addex Therapeutics Product
Table 123. Addex Therapeutics Recent Development
Table 124. Biogen Corporation Information
Table 125. Biogen Description and Business Overview
Table 126. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 127. Biogen Product
Table 128. Biogen Recent Development
Table 129. Eisai Corporation Information
Table 130. Eisai Description and Business Overview
Table 131. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 132. Eisai Product
Table 133. Eisai Recent Development
Table 134. Eli Lilly Corporation Information
Table 135. Eli Lilly Description and Business Overview
Table 136. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 137. Eli Lilly Product
Table 138. Eli Lilly Recent Development
Table 139. F. Hoffmann-La Roche Corporation Information
Table 140. F. Hoffmann-La Roche Description and Business Overview
Table 141. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 142. F. Hoffmann-La Roche Product
Table 143. F. Hoffmann-La Roche Recent Development
Table 144. H. Lundbeck Corporation Information
Table 145. H. Lundbeck Description and Business Overview
Table 146. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. H. Lundbeck Product
Table 148. H. Lundbeck Recent Development
Table 149. Impax Laboratories Corporation Information
Table 150. Impax Laboratories Description and Business Overview
Table 151. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Impax Laboratories Product
Table 153. Impax Laboratories Recent Development
Table 154. Kyowa Hakko Kirin Corporation Information
Table 155. Kyowa Hakko Kirin Description and Business Overview
Table 156. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 157. Kyowa Hakko Kirin Product
Table 158. Kyowa Hakko Kirin Recent Development
Table 159. Otsuka Pharmaceutical Corporation Information
Table 160. Otsuka Pharmaceutical Description and Business Overview
Table 161. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 162. Otsuka Pharmaceutical Product
Table 163. Otsuka Pharmaceutical Recent Development
Table 164. Pfizer Corporation Information
Table 165. Pfizer Description and Business Overview
Table 166. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 167. Pfizer Product
Table 168. Pfizer Recent Development
Table 169. Parkinson's Disease (PD) Drugs Market Trends
Table 170. Parkinson's Disease (PD) Drugs Market Drivers
Table 171. Parkinson's Disease (PD) Drugs Market Challenges
Table 172. Parkinson's Disease (PD) Drugs Market Restraints
Table 173. Parkinson's Disease (PD) Drugs Customers List
Table 174. Parkinson's Disease (PD) Drugs Distributors List
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Product Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Dopamine Agonist Product Picture
Figure 4. Monoamine Oxidase Inhibitors Product Picture
Figure 5. Acetylcholinesterase Inhibitors Product Picture
Figure 6. Glutamate Inhibitors Product Picture
Figure 7. Global Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Hospital
Figure 9. Family
Figure 10. Parkinson's Disease (PD) Drugs Report Years Considered
Figure 11. Global Parkinson's Disease (PD) Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Parkinson's Disease (PD) Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Parkinson's Disease (PD) Drugs Sales 2016-2027 (K Pcs)
Figure 14. Global Parkinson's Disease (PD) Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region (2016-2021)
Figure 16. Global Parkinson's Disease (PD) Drugs Sales Market Share by Region in 2020
Figure 17. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region (2016-2021)
Figure 18. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Region in 2020
Figure 19. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease (PD) Drugs Revenue in 2020
Figure 21. Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type (2016-2021)
Figure 23. Global Parkinson's Disease (PD) Drugs Sales Market Share by Type in 2020
Figure 24. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Type (2016-2021)
Figure 25. Global Parkinson's Disease (PD) Drugs Revenue Market

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs